Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study - Université de Rennes Accéder directement au contenu
Communication Dans Un Congrès Année : 2022

Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study

Domaines

Cancer

Dates et versions

hal-04069243 , version 1 (14-04-2023)

Identifiants

Citer

Cyrille Hulin, Aurore Perrot, Margaret Macro, Anne Vekhoff, Xavier Leleu, et al.. Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study. 64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.7133-7135, ⟨10.1182/blood-2022-159424⟩. ⟨hal-04069243⟩
48 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More